z-logo
open-access-imgOpen Access
Development of Generic Drug Products by Pharmaceutical Industries Considering Regulatory Aspects: A Review
Author(s) -
Md. Imtiaz Hasan,
Shahnaz Akter Shimu,
Akhi Akther,
Ishrat Jahan,
Md. Hamiduzzaman,
A. H. M. Nazmul Hasan
Publication year - 2021
Publication title -
journal of biosciences and medicines
Language(s) - English
Resource type - Journals
eISSN - 2327-509X
pISSN - 2327-5081
DOI - 10.4236/jbm.2021.910003
Subject(s) - innovator , generic drug , commercialization , new product development , biosimilar , drug development , product (mathematics) , business , risk analysis (engineering) , pharmaceutical industry , bioequivalence , computer science , drug , marketing , intellectual property , microbiology and biotechnology , pharmacology , medicine , mathematics , geometry , biology , bioavailability , operating system

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom